ARTICLES BY JYOTSNA JAJULA
-
![business leadership-GettyImages-2251075536]( "Will 2027 See A Meteoric Rise Of Programmable Nanomedicine?")
Will 2027 See A Meteoric Rise Of Programmable Nanomedicine?9/2/2026The significance of programmable nanomedicines is not simply that nanoparticles can carry more functions. It is that biological information can become part of the control logic.
Jyotsna Jajula
Jyotsna Jajula holds a master’s degree in Pharmaceutical Sciences with a research focus on lipid nanoparticles, RNA stability, and targeted delivery systems. Her research focuses on optimizing biodistribution and immunocompatibility of RNA therapeutics across oncology, immunology, and gene-therapy applications.